Cited by 212Digital Radiography and Breast ImagingCancer, Lipids, and MetabolismBreast Cancer Treatment Studies

The DOI matches its Crossref record; 50 of the 52 references it cites were found in a registry or an index.

CD36 Repression Activates a Multicellular Stromal Program Shared by High Mammographic Density and Tumor Tissues

Open access

Published version of a preprint

Abstract

Although high mammographic density is considered one of the strongest risk factors for invasive breast cancer, the genes involved in modulating this clinical feature are unknown. Tissues of high mammographic density share key histologic features with stromal components within malignant lesions of tumor tissues, specifically low adipocyte and high extracellular matrix (ECM) content. We show that CD36, a transmembrane receptor that coordinately modulates multiple protumorigenic phenotypes, including adipocyte differentiation, angiogenesis, cell–ECM interactions, and immune signaling, is greatly repressed in multiple cell types of disease-free stroma associated with high mammographic density and tumor stroma. Using both in vitro and in vivo assays, we show that CD36 repression is necessary and sufficient to recapitulate the above-mentioned phenotypes observed in high mammographic density and tumor tissues. Consistent with a functional role for this coordinated program in tumorigenesis, we observe that clinical outcomes are strongly associated with CD36 expression. Significance: CD36 simultaneously controls adipocyte content and matrix accumulation and is coordinately repressed in multiple cell types within tumor and high mammographic density stroma, suggesting that activation of this stromal program is an early event in tumorigenesis. Levels of CD36 and extent of mammographic density are both modifiable factors that provide potential for intervention. Cancer Discov; 2(9); 826–39. ©2012 AACR. Read the Commentary on this article by DeClerck, p. 772. This article is highlighted in the In This Issue feature, p. 753.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/2159-8290.cd-12-0107

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 52 references

2 of the 52 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Metadata

Authors
DeFilippis, R. A., Chang, H., Dumont, N., Rabban, J. T., Chen, Y.-Y., Fontenay, G. V., Berman, H. K., Gauthier, M. L., Zhao, J., Hu, D., Marx, J. J., Tjoe, J. A., Ziv, E., Febbraio, M., Kerlikowske, K., Parvin, B., & Tlsty, T. D.
Affiliations
Aurora Health Care (US)
Corresponding author
Tlsty, Thea D.
Venue
Cancer Discovery
Published
2012-09-01
Volume
2
Issue
9
Pages
826-839
ISSN
  • 2159-8274 (ISSN-L)
  • 2159-8290
OpenAlex
W2146971577
Cited by
212
References
52
Citations by year
2026: 5 · 2025: 16 · 2024: 16 · 2023: 15 · 2022: 14 · 2021: 24 · 2020: 36 · 2019: 15 · 2018: 17 · 2017: 7 · 2016: 12 · 2015: 13 · 2014: 8 · 2013: 10 · 2012: 4
FWCI
9.03
Type
journal article
Language
en
Open access
Locations
  • Cancer Discovery (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
National Cancer Institute (U54CA143803, P01CA107584)
Topics
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Digital Radiography and Breast Imaging
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
Keywords
CD36, breast density, breast cancer, tumor stroma, extracellular matrix, adipogenesis, adipose tissue, carcinogenesis, gene repression, tumor microenvironment, prognostic factors
MeSH terms
Animals, Breast Neoplasms, Cell Differentiation, Female, Humans, Mammography, Risk Factors, Signal Transduction, Stromal Cells, Adipocytes, Mice, Knockout, CD36 Antigens, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review